This lecture will demonstrate the standing in legal terms for the use of medicines 'off-label' in the adult population, with extrapolation to the child. Evidence based findings, regulatory view, and the legal aspect will be discussed. FDA Approval: How did we do it? An insight to the workings of the FDA and the need for lobbying to achieve a goal.
The organizers of the above course wish to invite you to participate in a 2-day concentration of experience and education in the new and exciting field of contrast-enhanced ultrasound (CEUS) in children. This is now an important aspect of imaging in children with recent Food and Drug Administration (FDA of the USA) approval of CEUS for characterisation of focal liver lesions and assessment of vesical-ureteric reflux. The organizers have extensive experience in the application of CEUS in children with over 10 years of accumulated knowledge, and wish to share this widely.
This is the 4 th occasion we are organizing this course, and this has grown to a full two days. The course is recognized as a EUROSON School, with full endorsement of the European Federation of Societies of Ultrasound in Medicine and Biology (EFSUMB) and is endorsed by the British Medical Ultrasound Society (BMUS), with continuing medical education credits provided by the Royal College of Radiologist, United Kingdom.
The aim is to attract participants from across Europe, and further afield, who have an interest in introducing CEUS for children, in whom the importance of radiation dose reduction and accurate imaging are paramount. It is hoped that the faculty as well as the participants will establish a worldwide network to encourage the use of CEUS in children. The aim is to bring together this experience with fruitful exchange of knowledge and experience.
We have put together a program that we hope will serve the needs of the participants, encourage discussion and subsequently increased clinical use.
The background to the development, safety and future developments of CEUS will be discussed, and the legal role in children explained. The use in focal liver lesions, benign and malignant will be discussed. CEUS in blunt abdominal trauma, vesical-ureteric reflux and in areas where only CEUS can be used as a problem solving tool will be demonstrated. Discussion around guidelines for CEUS, experience in Europe and the United States will be led by experts, and unusual case studies will be presented. Speakers who have recently set-up their own program of CEUS in children will share their experience. 
